Sarah Beshar
Known title: DirectorCIK: 0001706784
Associated companies
Transaction History
| IVZ | ▲ Buy | Grant | 8,112 | $0 | 5/15/2026 | View on chart |
| IVZ | ▲ Buy | Grant | 12,728 | $0 | 5/15/2025 | View on chart |
| IVZ | ▲ Buy | Grant | 11,955 | $0 | 5/15/2024 | View on chart |
| IVZ | ▲ Buy | Grant | 12,820 | $0 | 5/15/2023 | View on chart |
| IVZ | ▲ Buy | Grant | 10,930 | $0 | 5/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Invesco to Report Q3 2026 Results; Dividends Declared
Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.
Invesco to Report Q3 2026 Results; Dividends Declared. Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.